drugset / Trial / NCT02427243
A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous Dose
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the relative bioavailability and tolerability of two different formulations of crenezumab in approximately 60 healthy volunteers.
Timeline
- Start
- 2015-04
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crenezumab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.